Position in LH
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$29,552,040
+$692,271 QoQ
Shares Held
105,543
-2.4% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#91
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026KBC Group NV holds $446,284,356 across 25 Diagnostics & Research names. LH ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
747,974 | $144,523,534 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
197,810 | $99,174,020 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
113,614 | $59,810,953 | |
| 4 | DHR |
Danaher Corp /De/
|
268,957 | $51,230,928 | |
| 5 | LH |
Labcorp Holdings Inc.
This page
|
105,543 | $29,552,040 | |
| 6 | DGX |
Quest Diagnostics Inc
|
54,912 | $11,638,597 | |
| 7 | A |
Agilent Technologies, Inc.
|
81,883 | $10,876,518 | |
| 8 | ILMN |
Illumina, Inc.
|
54,388 | $9,563,041 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,552,040 | 105,543 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $28,859,769 | 108,166 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $28,510,253 | 113,641 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $30,569,019 | 106,490 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $27,952,064 | 106,480 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $24,218,923 | 104,060 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $23,383,072 | 101,967 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $21,187,691 | 94,808 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $20,139,755 | 98,962 | Shares | Defined | 2024-07-17 | |
| No filing history on record for this holder in this stock. | ||||||